volume 191, issue 4, P1606-1613 2013
DOI: 10.4049/jimmunol.1301116
View full text
|
|
Share
Ashley R. Sandy, Josh Stoolman, Kelli Malott, Prae Pongtornpipat, Benjamin M. Segal, Ivan Maillard

Abstract: Systemic inhibition of Notch signaling was previously shown to attenuate experimental autoimmune encephalomyelitis (EAE), a disease model of multiple sclerosis in mice. Different studies attributed these effects to decreased T-bet and IFNγ expression, enhanced regulatory T cell function, reduced T cell chemotaxis to the central nervous system (CNS) or impaired Th9 cell differentiation. Interpretation of these heterogeneous findings is difficult, since past experimental strategies did not ensure complete Notch…

expand abstract